Ziegler Capital Management, LLC Amphastar Pharmaceuticals, Inc. Transaction History

Ziegler Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$27.99 - $37.92 $7,557 - $10,238	270 Added 0.99%	27,637 $1.04 Million
Q4 2022 Jan 24, 2023	SELL	$27.93 - $31.27 $178,193 - $199,502	-6,380 Reduced 18.91%	27,367 $0
Q3 2022 Oct 25, 2022	SELL	$27.56 - $37.75 $5,484 - $7,512	-199 Reduced 0.59%	33,747 $948,000
Q2 2022 Jul 21, 2022	BUY	$29.79 - $42.29 $22,848 - $32,436	767 Added 2.31%	33,946 $1.18 Million
Q1 2022 May 04, 2022	SELL	$22.96 - $36.45 $61,992 - $98,415	-2,700 Reduced 7.53%	33,179 $1.19 Million
Q4 2021 Feb 09, 2022	SELL	$18.14 - $23.29 $210,496 - $270,257	-11,604 Reduced 24.44%	35,879 $836,000
Q3 2021 Oct 27, 2021	BUY	$17.83 - $21.49 $244,912 - $295,186	13,736 Added 40.7%	47,483 $903,000
Q2 2021 Jul 21, 2021	BUY	$17.11 - $20.92 $577,411 - $705,987	33,747 New	33,747 $680,000

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ziegler Capital Management, LLC with notifications on news.